Standards of Care for Opioid Prescribing: What Every APRN Prescriber and Investigator Need to Know

      Opioid misuse is becoming an epidemic. Knowledge of nationally vetted standardized methods of pain assessment, safe treatment options and modalities, and follow-up evaluation for patients on opioids is essential for health care providers. This article outlines the current standards of care for pain management and safe opioid prescribing that are necessary for APRNs and other providers prescribing opioids. These guidelines should serve as the standards of care for prescribers, as well as boards of nursing and their investigators when evaluating violations that involve poor or inappropriate prescribing, abuse, and other issues related to opioid prescribing.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Nursing Regulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Society of Addiction Medicine
        Opioid addiction disease 2015 factsheet. 2015 (Retrieved from)
        • American Society of Interventional Pain Physicians
        Guidelines for responsible opioid prescribing in chronic non-cancer pain. 2012 (Retrieved from)
        • Arnold R.
        • Claxon R.
        Screening for opioid misuse and abuse.
        (Retrieved from)
        • Breuer B.
        • Cruciani R.
        • Portenoy R.K.
        Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: A national survey.
        Southern Medical Journal. 2010; 103: 739-747
        • Buppert C.
        New standards of care for prescribing opioids.
        (Retrieved from)
        • Cheatle M.D.
        • Savage S.R.
        Informed consent in opioid therapy: A potential obligation and opportunity.
        Journal of Pain and Symptom Management. 2012; 44: 105-116
        • Chou R.
        • Fanciullo G.J.
        • Fine P.G.
        • Adler J.A.
        • Ballantyne J.C.
        • Davaies P.
        • Maskowski C.
        • American Pain Society, American Academy of Pain Medicine Opioids Guidelines Panel
        Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.
        The Journal of Pain. 2009; 10: 113-130
        • Franklin G.
        • American Academy of Nephrology
        Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology.
        Neurology. 2014; 83: 1277-1284
        • Institute of Medicine
        Relieving pain in America: A blueprint for transforming prevention, care, education, and research. The National Academies Press, Washington, DC2011: 1-18
        • The Joint Commission
        Facts about pain management.
        (Retrieved from)
        • National Institute on Drug Abuse
        Chart of evidence-based screening tools for adults and adolescents.
        (Retrieved from)
        • National Institute on Drug Abuse
        Marijuana research at NIDA.
        (Retrieved from)
        • Office of National Drug Control Policy
        Prescription drug monitoring programs. 2011 (Retrieved from)
        • PainEDU
        Opioid risk management. 2015 (Retrieved from)
        • Starrels J.L.
        • Becker W.C.
        • Alford D.P.
        • Kapoor A.
        • Williams A.R.
        • Turner B.J.
        Systematic review: Treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain.
        Annals of Internal Medicine. 2010; 152: 712-720
        • Starrels J.L.
        • Becker W.C.
        • Weiner M.G.
        • Li X.
        • Heo M.
        • Turner J.
        Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain.
        Journal of General Internal Medicine. 2011; 26: 958-964
        • Substance Abuse and Mental Health Services Administration
        Results from the 2012 national survey on drug use and health: Summary of national findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795, Rockville, MD2013
        • Sullivan M.D.
        • Edlund M.J.
        • Fan M.Y.
        • DeVries A.
        • Braden J.B.
        • Martin B.C.
        Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: The TROUP Study.
        Pain. 2010; 150: 332-339
        • U.S. Department of Health and Human Services
        Addressing prescription drug abuse in the United States: Current activities and future opportunities.
        (Retrieved from)
        • U.S. Food and Drug Administration
        Approved risk evaluation and mitigation strategies (REMS). 2015 (Retrieved from)
        • Van Pelt J.
        Pain care advocacy in an era of opioid abuse.
        Social Work Today. 2012; 1: 16
        • Williamson A.
        • Hoggart B.
        Pain: A review of three commonly used pain rating scales.
        Journal of Clinical Nursing. 2005; 14: 798-804